This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (28)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Another View

Martin A. Adson, MD

Arch Surg. 1989;124(9):1023-1024.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

I am sympathetic with Dr Silen's¹ concern about the indications for resection of hepatic metastases, because I have been guided by such reservations for 30 years. However, I do not accept his condemnation of beliefs that have been acquired cautiously and rationally throughout these years. I think there is some validity where he has found none, and I am convinced that some people who have hepatic metastases will live much longer if their liver lesions are removed. There is a small, well-defined group of patients who must not be assigned to therapeutic trials that would deny half of them their only chance for extended survival. Thus, we have a difference of opinion that at first seems to be absolute. Nevertheless, I think that something good can come from an examination of this disagreement.

The uncertainties that we share relate to the nature of controls, the differences between total populations . . . [Full Text PDF of this Article]

Author Affiliations
From the Department of Surgery, Mayo Medical School, Rochester, Minn. Reprint requests to Department of Surgery, Mayo Clinic, Rochester, MN 55905 (Dr Adson).

Footnotes
Accepted for publication April 28, 1989.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?